Veklury – Talk Bio

Actionable Insights Powered by AI

Gilead Exceeds COVID-19 Drug Sales Projections, Faces $1.75 Billion Loss on Trodelvy Trial Failure

9 months ago talkbio0Tagged Clinical Trials, COVID19 (disease), drug sales, Failure (biologic function), Gilead, Trodelvy, Veklury

Gilead, COVID-19, Veklury, Trodelvy, drug sales, clinical trial failure

Gilead Sciences Surpasses Q3 Earnings and Sales Forecasts, Boosts Annual Outlook

9 months ago talkbio0Tagged Advice, annual, Biktarvy, earnings, Gilead Sciences, HIV, HIV Prevention, Lenacapavir, Veklury

Gilead Sciences, Q3 earnings, HIV drug sales, annual guidance, Biktarvy, Veklury, lenacapavir, HIV prevention